EA201290817A1 - Твердые фармацевтические композиции рамиприла и безилата амлодипина и их получение - Google Patents

Твердые фармацевтические композиции рамиприла и безилата амлодипина и их получение

Info

Publication number
EA201290817A1
EA201290817A1 EA201290817A EA201290817A EA201290817A1 EA 201290817 A1 EA201290817 A1 EA 201290817A1 EA 201290817 A EA201290817 A EA 201290817A EA 201290817 A EA201290817 A EA 201290817A EA 201290817 A1 EA201290817 A1 EA 201290817A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
ramipril
amylodypine
dilated
free
Prior art date
Application number
EA201290817A
Other languages
English (en)
Inventor
Нилеш Джайсваль
Правин Кхуллар
Амол Кулкарни
Дилип Праджапати
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42786564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201290817(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Publication of EA201290817A1 publication Critical patent/EA201290817A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D11/00—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material
    • B65D11/20—Details of walls made of plastics material

Abstract

Настоящее изобретение относится к твердым стабильным фармацевтическим композициям фиксированных доз, содержащим рамиприл, безилат амлодипина и фармацевтически приемлемые эксципиенты, и к их получению.
EA201290817A 2010-02-24 2010-04-14 Твердые фармацевтические композиции рамиприла и безилата амлодипина и их получение EA201290817A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN417DE2010 2010-02-24
PCT/IB2010/051616 WO2011104588A2 (en) 2010-02-24 2010-04-14 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation

Publications (1)

Publication Number Publication Date
EA201290817A1 true EA201290817A1 (ru) 2013-01-30

Family

ID=42786564

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290817A EA201290817A1 (ru) 2010-02-24 2010-04-14 Твердые фармацевтические композиции рамиприла и безилата амлодипина и их получение

Country Status (28)

Country Link
US (1) US20130146496A1 (ru)
EP (1) EP2538924B1 (ru)
JP (1) JP5719385B2 (ru)
KR (1) KR20120130761A (ru)
CN (1) CN102781430B (ru)
AR (1) AR080256A1 (ru)
AU (1) AU2010346977A1 (ru)
BR (1) BR112012021203A2 (ru)
CA (1) CA2790817A1 (ru)
CL (1) CL2012002341A1 (ru)
CR (1) CR20120432A (ru)
EA (1) EA201290817A1 (ru)
EC (1) ECSP12012121A (ru)
ES (1) ES2483154T3 (ru)
GT (1) GT201200248A (ru)
MA (1) MA34130B1 (ru)
MX (1) MX2012009689A (ru)
NI (1) NI201200136A (ru)
PE (1) PE20130004A1 (ru)
PL (1) PL2538924T3 (ru)
SG (1) SG183449A1 (ru)
SI (1) SI2538924T1 (ru)
TN (1) TN2012000363A1 (ru)
TW (1) TW201138767A (ru)
UA (1) UA105285C2 (ru)
UY (1) UY33243A (ru)
WO (1) WO2011104588A2 (ru)
ZA (1) ZA201205559B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113977C2 (xx) * 2012-02-17 2017-04-10 Фармацевтична композиція з покращеною стабільністю
PL227900B1 (pl) 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN104546773B (zh) * 2015-01-30 2018-12-11 华润赛科药业有限责任公司 一种高稳定性苯磺酸氨氯地平片及其制备方法
WO2016207824A2 (en) * 2015-06-23 2016-12-29 Dr. Reddy's Laboratories Ltd A stable pharmaceutical composition comprising ramipril and/or amlodipine
EP3501502A1 (en) * 2017-12-20 2019-06-26 Midas Pharma GmbH Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633496A1 (de) 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
PT804229E (pt) 1995-03-16 2003-06-30 Pfizer Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica
WO2001015674A2 (en) 1999-08-30 2001-03-08 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
WO2005079772A2 (en) 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
HUP0401170A2 (en) * 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
EP1817007A2 (en) * 2004-11-05 2007-08-15 King Pharmaceuticals Research and Development Inc. Stabilized individually coated ramipril particles, compositions and methods
CN101272791A (zh) * 2005-09-28 2008-09-24 特瓦制药工业有限公司 苯磺酸氨氯地平和盐酸贝那普利的稳定的组合
AU2005336956A1 (en) * 2005-09-28 2007-04-12 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
US20080096863A1 (en) * 2006-10-19 2008-04-24 Torrent Pharmaceuticals Limited Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor

Also Published As

Publication number Publication date
NI201200136A (es) 2012-10-29
GT201200248A (es) 2014-05-14
MA34130B1 (fr) 2013-04-03
ZA201205559B (en) 2013-09-25
TW201138767A (en) 2011-11-16
AU2010346977A1 (en) 2012-09-13
AR080256A1 (es) 2012-03-21
MX2012009689A (es) 2012-09-12
CN102781430B (zh) 2015-09-09
PL2538924T3 (pl) 2014-10-31
UY33243A (es) 2011-09-30
SG183449A1 (en) 2012-09-27
KR20120130761A (ko) 2012-12-03
JP2013520485A (ja) 2013-06-06
US20130146496A1 (en) 2013-06-13
WO2011104588A3 (en) 2012-04-19
PE20130004A1 (es) 2013-02-01
EP2538924B1 (en) 2014-05-21
CA2790817A1 (en) 2011-09-01
EP2538924A2 (en) 2013-01-02
BR112012021203A2 (pt) 2016-05-17
WO2011104588A2 (en) 2011-09-01
ES2483154T3 (es) 2014-08-05
CR20120432A (es) 2012-11-29
UA105285C2 (ru) 2014-04-25
CL2012002341A1 (es) 2012-11-30
TN2012000363A1 (en) 2014-01-30
JP5719385B2 (ja) 2015-05-20
CN102781430A (zh) 2012-11-14
ECSP12012121A (es) 2012-09-28
SI2538924T1 (sl) 2014-09-30

Similar Documents

Publication Publication Date Title
EA201270087A1 (ru) Твердые фармацевтические композиции с фиксированной дозой, содержащие ирбесартан и амлодипин, их получение и их терапевтическое применение
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
EA201492214A1 (ru) Ингибиторы вируса гепатита с
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
EA201300146A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA201290817A1 (ru) Твердые фармацевтические композиции рамиприла и безилата амлодипина и их получение
GEP20135859B (en) Stable combined pharmaceutical composition
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
EA201500245A1 (ru) Твердый фармацевтический препарат, который содержит левотироксин
EA201500513A1 (ru) Продукт сомикронизации, включающий ацетат улипристала
EA201690395A1 (ru) Стабильная фармацевтическая композиция, содержащая бисопролол и рамиприл
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
EA201291420A1 (ru) Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли
EA201590886A1 (ru) Замещенные производные индола
EA201101703A1 (ru) 17β-АЛКИЛ-17α-ОКСИЭСТРАТРИЕНЫ
TR201005419A2 (tr) Valsartan içeren farmasötik bileşim.